InnovAge Holding Corp. Revenue from Related Parties
InnovAge Holding Corp. (INNV) reported Revenue from Related Parties of $35.00 thousand for the 9-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2023-05-09
- InnovAge Holding Corp. revenue from related parties for the quarter ending 2023-03-31 was $0.00.
- InnovAge Holding Corp. revenue from related parties for the quarter ending 2022-12-31 was $0.00.
- InnovAge Holding Corp. revenue from related parties for the quarter ending 2022-09-30 was $35.00K, a 0.00% change year-over-year.
- InnovAge Holding Corp. revenue from related parties for the quarter ending 2022-06-30 was $0.00.
- InnovAge Holding Corp. revenue from related parties for fiscal 2022 was $35.00K, a 0.00% change from fiscal 2021.
- InnovAge Holding Corp. revenue from related parties for fiscal 2021 was $35.00K.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 6 month | Revenue from Related Parties 9 month | Revenue from Related Parties 12 month |
|---|---|---|---|---|
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | $35.00K 10-Q · filed 2023-05-09 | $35.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $35.00K 10-Q · filed 2023-02-07 | $35.00K derived: sum of 3 quarters · filed 2023-02-07 | $35.00K derived: sum of 4 quarters · filed 2023-02-07 |
| 2022-09-30 | $35.00K 10-Q · filed 2022-11-08 | $35.00K derived: sum of 2 quarters · filed 2022-11-08 | $35.00K derived: sum of 3 quarters · filed 2022-11-08 | $35.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $0.00 derived: sum of 2 quarters · filed 2022-09-13 | $0.00 derived: sum of 3 quarters · filed 2022-09-13 | $35.00K 10-K · filed 2022-09-13 |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-05-10 | $35.00K 10-Q · filed 2022-05-10 | $35.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | $35.00K 10-Q · filed 2022-02-09 | $35.00K derived: sum of 3 quarters · filed 2022-02-09 | |
| 2021-09-30 | $35.00K 10-Q · filed 2021-11-09 | $35.00K derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $35.00K 10-K · filed 2021-09-23 | ||
| 2021-03-31 | $35.00K 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |